BioSpace News Archive

Business

Varex Imaging Announces Financial Results for First Quarter of Fiscal Year 2018

Varex Imaging today announced its financial results for the first quarter of fiscal year 2018.

February 1, 2018

·

25 min read

Business

Aethlon Medical Announces Fiscal 2018 Third Quarter Results

Aethlon Medical today announced results for its fiscal third quarter ended December 31, 2017.

February 1, 2018

·

19 min read

Drug Development

AnaBios Release: Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model

For this research, human ventricular trabeculae isolated from ethically-consented organ donors were used to assess the effects of 13 blinded clinical reference drugs on cardiac action potential.

February 1, 2018

·

2 min read

Policy

Alnylam Announces FDA Acceptance of New Drug Application (NDA) and Priority Review Status for Patisiran, an Investigational RNAi Therapeutic for the Treatment of Hereditary ATTR (hATTR) Amyloidosis

Alnylam announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for patisiran, an investigational RNAi therapeutic targeting transthyretin (TTR) for the treatment of hereditary ATTR (hATTR) amyloidosis.

February 1, 2018

·

7 min read

ErgoMed Release: Completion of Placing Raising Approximately £3.9 Million for Selected Acquisitions to Augment the Growth of its Services Businesses, Capital Expenditure and Additional Working Capital

ErgoMed of 2,029,971 new Ordinary Shares at 190p per share to raise gross proceeds of approximately £3.9 million.

February 1, 2018

·

3 min read

BioMidwest

Cardiovascular Systems, Inc. Announces Commercial Launch in Japan

Cardiovascular Systems announced today that it has commercially treated the first patient in Japan with its Diamondback 360® Coronary OAS Micro Crown (Micro Crown).

February 1, 2018

·

7 min read

Cmed to Showcase Own eSource Technology at SCOPE 2018

At SCOPE, Cmed will also demonstrate how to improve the capture and management of data from different sources and review them in live insights, finding answers to your questions immediately.

February 1, 2018

·

2 min read

FDA

FDA Approves Allergan’s AVYCAZ (ceftazidime and avibactam) for the Treatment of Patients With Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Allergan today announced that the FDA has approved Allergan’s sNDA to expand the approved use of AVYCAZ.

February 1, 2018

·

13 min read

Drug Development

InflaRx Presents at Two Scientific Conferences in February, 2018

InflaRx N.V. will present data on IFX-1, an anti-C5a monoclonal antibody, at two international scientific conferences.

February 1, 2018

·

3 min read

Business

Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX (neratinib) in Greater China

CANbridge Life Sciences announced today that it has licensed the exclusive rights to develop and commercialize NERLYNX (neratinib) in China, Taiwan, Hong Kong and Macao (collectively, greater China) from Puma Biotechnology.

February 1, 2018

·

3 min read